Investec Downgrades Oxford Biomedica to Hold, Cuts PT

MT Newswires · 3d ago
08:31 AM EDT, 08/13/2026 (MT Newswires) -- Investec on Thursday downgraded British gene and cell therapy company Oxford Biomedica (OXB.L) to hold from buy and reduced its price target to 5.08 pounds sterling from 8.26 pounds. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)